Joseph R. Moskal
Corporate Officer/Principal chez Northwestern University
Profil
Joseph R.
Moskal was the founder of Naurex, Inc. (founded in 2006) and Aptinyx, Inc. (founded in 2015), where he held the title of Chief Scientific Officer.
He is currently the Director-Falk Center for Molecular Therapeutics at Northwestern University since 2013.
Previously, he worked as the Director-Neurosurgery Laboratories at Albert Einstein College of Medicine, Inc. Dr. Moskal completed his undergraduate and doctorate degrees at the University of Notre Dame.
Postes actifs de Joseph R. Moskal
Sociétés | Poste | Début |
---|---|---|
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - |
Anciens postes connus de Joseph R. Moskal
Sociétés | Poste | Fin |
---|---|---|
Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
APTINYX | Fondateur | - |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Fondateur | - |
Formation de Joseph R. Moskal
University of Notre Dame | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
APTINYX | Health Technology |
Entreprise privées | 1 |
---|---|
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |